Detalhe da pesquisa
1.
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Proc Natl Acad Sci U S A
; 109(17): 6662-7, 2012 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-22451913
2.
Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer - A Feasibility Study.
Geburtshilfe Frauenheilkd
; 83(9): 1138-1147, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37706056
3.
Neutrophil and monocyte kinetics play critical roles in mouse peritoneal adhesion formation.
Blood Adv
; 3(18): 2713-2721, 2019 09 24.
Artigo
Inglês
| MEDLINE | ID: mdl-31519647
4.
Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variants.
Oncoimmunology
; 2(9): e25773, 2013 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24319639
5.
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.
Science
; 341(6141): 88-91, 2013 Jul 05.
Artigo
Inglês
| MEDLINE | ID: mdl-23722425
6.
Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancer.
Oncol Lett
; 3(3): 530-534, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22740945